Our investigation demonstrated that disruption of JAK2‐STAT4 pathway by Xa contributed to its inhibitory effects on the expression of BARD1 and HR pathway in NSCLC cells (Figure 7). This evidence concerns the gene JAK2 and non-small cell lung carcinoma.